Transcription
Global Medical Affairs and Outcomes Research2022 Fellowship Program
Global MA&ORFellowship ProgramTable ofcontentsWelcome . . 3About Organon . . 4-5Three Key Areas . . . 6-7Our Values . . . . 8Fellowship Overview . 9Your Fellowship Team . .10Program Overview . . . 11-15RPIF Program . 16-19
Table of ContentsWelcomeOrganon Global MA&OR Fellowship Program in Partnership withOn behalf of Organon and the Ernest Mario School of Pharmacy at Rutgers, TheState University of New Jersey, we thank you for your interest in our OrganonGlobal Medical Affairs & Outcomes Research (MA&OR) Fellowship Program.Organon is a Women’s Health Company that believes in a better and healthierevery day for every woman! We are a passionate, global community ofthousands dedicated to our goal of redefining the future of women’s health.Our mission is to deliver impactful medicines and solutions for a healthier every day.But what really makes it work at Organon is our people.We’re looking for fellows who are real, passionate team players, curious innovators,forward thinkers, empowered by the idea of shaping their career, and ready to bringtheir fire to embrace change and the opportunities it brings for progress. Asfounding fellows, you’ll have the unique opportunity to contribute to thedevelopment of our company and help shape our culture.Through the Organon MA&OR Fellowship Program, we strive to provide a dynamic,highly immersive program in an entrepreneurial pharmaceutical industryenvironment.We look forward to meeting you and we wish you the best of luck throughout thisrecruitment process and the next steps of your career.3
Table of ContentsAbout OrganonOur StoryOrganon has important links to the past in terms of products and its passion for women’s health.Organon launched on June 3, 2021, as a global women’s health company with employees andwomen from around the world.Organon was selected as our company name to communicate the promise of the future, whileanchoring to a legacy of innovation in women’s health.Organon was at the forefront of innovation in women’s reproductive health.The word organon has its roots in ancient Greek and means “an instrument for acquiringknowledge.” Organon became the name of a Netherlands-based company that was establishedin 1923, and which grew as a European innovator and became known in the area of women’shealth.Photo above shows the Organon leadership team on thismomentous day including Kevin Ali, CEO & Chairman(standing second from left) and Sandy Milligan, Head ofResearch & Development (seated).Our mission: is to deliver impactful medicines and solutions for a healthier every day.4
Table of ContentsAbout OrganonOur company“As a new company, we expect business development tobe a core part of our growth strategy. We search acrossthe entire horizon for potential solutions—be theymedicines, devices, or other technologies—that canimprove the health of women. There will be numerousopportunities for fellows to gain a unique and diverseexperience and make significant contributions to projectsand the teams they are on.Organon is a global healthcare company with a mission to deliverimpactful medicines and solutions for a healthier every day. We buildupon our strong foundation of more than 60 medicines and otherproducts across a range of areas including reproductive health, heartdisease, dermatology, allergies and asthma.We bring these important therapies around the world, with aninternational footprint that serves people in more than 140markets. We believe the diversity of our business provides asustainable engine of growth so we can continue to invest in andadvance new medicines and treatments for women that are sourgently needed.While Organon will focus on women’s health, we have anexpansive portfolio that consists of established brands andbiosimilars that we deliver to patients around the world.Our fellows will be able to drive their experience and focuson areas that interest them the most as they prepare toembark on their future career.”We are here for her health.Edio ZampaglioneVP Head of MA&ORExecutive Sponsor5
Table of ContentsOur Three Key sOur three pillars — women’s health, biosimilars and established medicines — are the foundation for how we striveto achieve our vision to create a better and healthier every day. We work to provide medicines and other products thathelp address a wide array of conditions and diseases that women and their loved one’s face. Our hope is to give peoplemore choice throughout their lives.6
Table of ContentsOur Three Key AreasWomen’s HealthWe know women need more choices whenit comes to their healthcare. We believethat women are the foundation to ahealthier world.Our goal is to create a better andhealthier every day, for every womanWe are motivated by a woman’s evolvinghealth needs throughout her lifetime.That’s why our intention is to take on someof the issues that matter most to her.We aim to empower women to make theright health choices for them with anambition to help women achieve theirfamily goals.BiosimilarsEstablished MedicinesWe prioritize our patients first throughlistening, learning and understanding theirneeds. As the biosimilar landscape changes,so do we – with an unwavering commitmentto providing more options for patients.Bringing important medicines to patientsin needBiosimilars were introduced with the goal ofoffering patients more treatment options andreducing healthcare costs related tobiologics. Through the adoption ofbiosimilars, it is estimated that the healthcare system could save 104 billion from2020 to 2024.7Our portfolio of established medicineshas a long history across a range oftherapeutic areas.Providing a range of medicines acrossdiseases and conditionsOur established brands include wellknown products across a range oftherapeutic areas like respiratory,cardiovascular, dermatology, non-opioidpain and more.
Table of ContentsOrganon’sGlobalLocationsOrganon’s productsare available to peoplein more than 135countries. We haveestablished a footprintin 62 countries, havecollaborations in morethan 80 countries,and providedesignated point ofcontact (DPOC)services in more than180 countries. Ourheadquarters arebased in Jersey City,NJ, USA.Our ValuesOur people take the promise of Organon and turn it into a reality, with a calling to helpcreate what has been missing in the world. Above all, we act with integrity becausewe are the foundation for what the company will become, and our values are how weget things done around here.Be real.We will be authentic andtransparent.We all belong.We will see diversity as critical to all wedo, making sure everyone has a voiceand feels a sense of belonging.Own it.We will drive accountability andempowerment with highintegrity and ethical standards.Rise together.We will collaborateand succeed as ateam.8Bring your fire.We will maintain passionfor our purpose and whatwe do.Keep moving.We will be entrepreneurial andresilient, lean into challenges andembrace change.
Table of ContentsGlobal MA&OR Fellowship Program OverviewDuring the two-year Organon Fellowship, our founding fellows will gain a wellrounded understanding of Global Medical Excellence and Global MedicalAffairs Capabilities (GMAC) including: Global Medical Customer Interface (GMCI)o Medical Information and Contact CenterStrategic Medical Communications and Channels (SMCC)o “After having many years of experience with the RutgersFellowship Program, I know the caliber of talent that comes withthis group of new professionals! This will be an amazing andstimulating experience focusing the key capabilities in MedicalAffairs and Outcomes Research. At Organon, all we ask is to“Bring your Fire” to fiercely advocate for those we serve.”- Rebecca Lakata(Associate Vice President MA&OR, Executive Sponsor)Global Medical Content and TrainingGlobal Field Medical Center of Excellence (FM COE)Opportunities for growth within other departments, such asAdvertising Promotion Review (APR) in the commercialorganization and broad visibility of Business Development (BD).These growth opportunities align with Organon’s strategy to focuson product development to support unmet and under-met needs infuture growth opportunities across Women’s Health.This two-year Fellowship will allow fellows to work in many key therapeuticareas, including reproductive health, heart disease, dermatology, allergies andasthma. Fellows will also receive ample exposure to the Global market asOrganon maintains an international footprint that serves people in morethan 135 countries. Fellows will join Organon founders in building a brand,nurturing our existing portfolio, and expanding into new areas.9
Table of ContentsYour Fellowship TeamPoonam Bordoloi leads the Global Medical Affairs Capabilities (GMAC) team at Organon. She has oversight over MedicalReview of Promotional Materials, Medical Information, and the Designated Point of Contact center. Poonam has over 25 yearsof experience in the Medical Affairs setting and has two publications regarding social media and medical information trends.Poonam is a DIA planning board member and is currently serving a three-year term for the Medical Communications/MedicalWriting Track for DIA Annual. She chaired the 2019 DIA Med Comm meeting and continues to be actively involved. Poonamgraduated from Rutgers College of Pharmacy and completed her PharmD from Shenandoah University.Poonam BordoloiPharmD – Fellowship DirectorTaeho Lim is Associate Director of Global Medical Information at Organon. He is a proud alumnus of Massachusetts College ofPharmacy and Health Sciences. His experience spans from Medical Communications to Global Medical Information. He is excited tolead future pharmacy fellows and ensure that each participant has a hands-on and fully immersed experience. Taeho is looking forwardto being a part of the growth of each fellow and being able to guide them through the many unique opportunities at Organon.Taeho LimPharmD – PreceptorNancy Park is Director of Strategic Medical Content and Channels at Organon and a proud alumnus of the RPIF program. She brings 20 years of pharmaceutical industry experience primarily within the Medical Affairs capacity in Medical Information, as a MedicalScience Liaison, a Director of Medical Affairs, and as a Payer Clinical Strategist for a marketing agency. As preceptor, she looks forwardto working closely with fellows as they gain hands-on experience and explores the breadth of unique opportunities within the GlobalMA&OR team at Organon.Nancy ParkPharmD, MBA – Preceptor10
Table of ContentsProgram OverviewThroughout the two-year program, there will be a focus on digital innovation and high-impact projects that align with businessdevelopment opportunities. During their first year, Fellows will rotate between GMCI and SMCC at six-month intervals. During the secondyear, fellows will have the opportunity to select two six-month elective rotations to work closely with Commercial (APR), Medical Affairs(Medical Excellence or FM COE), or continue their work within GMCI and/or SMCC, dependent on workload. A concerted effort will be made tointegrate the fellows into special projects for their professional development and to expose them to multiple facets of the pharmaceuticalindustry, with a focus in the Medical Affairs organization. Longitudinal experience regarding business development and digital innovationacross the organization will be on an as needed basis spanning the length of the two-year program.Global MedicalCustomer Interface6 monthsStrategic MedicalCommunicationsand Channels6 monthsElective Rotation*6 monthsElective Rotation*6 monthsBusiness development opportunities, as appropriate*Elective rotations include Advertising Promotion Review (APR), Global Field Medical Center ofExcellence (FM COE), Global Medical Excellence (Operations), Global Medical Customer Interface (GMCI)or Strategic Medical Communications and Channels (SMCC).11Organon is committed to theprofessional and personal developmentof fellows through diverse opportunitiesas an active member of the Organonteam. Our goal is for our fellows to befully prepared to continue their careertrajectory within the pharmaceuticalindustry, including the potential forthem to join Organon through apermanent position.
Table of ContentsFirst Year OverviewGlobal Medical Customer Interface(Six months)Fellows will have the opportunity to: Gain access to and experience the daily functions ofGMCI which includes, providing accurate, timely andunbiased responses to unsolicited Medical InformationRequests (MIRs) Provide medical review of promotional materials toverify scientific accuracy of content and minimizecompliance risk to the company and Scientific Exchangematerials. Collaborating with commercial and medicalstakeholders on sales training initiatives to determine howbest to leverage and train the Global Sales Force in anethical and compliant manner. Interact cross-functionally with many departments,including Learning and Development, Global Safety,Organon Service Center, Outcomes Research, Legal,Compliance, Local Regional Teams, Strategic Operations,and US and Global Marketing."Now is an exciting time to join Organon and be part of the founder’s teamthat is defining what it means to be a Women’s Healthcare Company."The Rutgers Fellowship program at Organon allows graduates toexperience opportunities in different areas of the company, based on theirinterests. Fellows’ unique perspectives and ideas keep our company currentand at the forefront of industry standards.“- Diane Krawiec-LitwinkoTeam Lead, Global Medical Customer InterfaceExecutive Sponsor12
Table of ContentsFirst Year OverviewStrategic Medical Communicationsand Channels(Six months)Fellows will have an opportunity to: Be integrated into the SMCC team as a strategicpartner to the Women’s Health, Biosimilars, andEstablished Brands franchises Participate in strategic planning sessions with GlobalMedical Therapeutic Area Leads to help developinnovative medical content and comprehensive trainingmaterial that are aligned to Global Medical Affairs Plansfor each respective franchise Assist in the development of timely, fit-for-purposeresources and training to support global launch activities Facilitate the strategic integration of digitalinnovation to communicate global medical content Participate in global publication planning committeesand support global medical congress activitiesHold for photo“Organon is a brand-new company and the challenges of setting upteams, policy, processes, technology are unique to a start-up. It’s aonce-in-a-lifetime opportunity to develop the future ways of workingfrom scratch and represents a uniquely valuable experience.”- Scott SummersTeam Lead, Strategic Medical Communications and ChannelsExecutive Sponsor13
Table of ContentsSecond Year OverviewAdvertisingPromotion ReviewGlobal Field MedicalCenter of Excellence(Six months)(Six months)Fellows will have the opportunity to: Work collaboratively with PromotionalReview Team (PRT) members and thecommercial organizations to ensure thatpromotional practices are consistent withFDA regulatory guidelines and supportbusiness objectives Assist with review and approval ofUS promotional materials Help to execute quality controlmanagement, inspection, and oversightfor proposed submission materials to FDA Support the development andimplementation of effective strategiesfor FDA promotional submissionsFellows will have the opportunity to: Help to build a brand-new Global FieldMedical Center of Excellence whose missionwill be to enhance patient care by optimizingimpactful scientific exchange and building ahigh-performing field medical team Assist in developing Field Medical DigitalInnovation (i.e., roster management, insightsmanagement, field medical platform) to optimizethe quality of scientific exchange and maximizefield medical engagement with key decisionmakers Participate in the development of tools andtemplates strategically aligned to the fieldmedical engagement plans, as well as thebenchmarking, collection, analyzation andreporting of metrics14“The Global FieldMedical Center ofExcellence is excited towelcome the RutgersFellows. Theseindividuals will have theopportunity to help makea difference in the livesof women, their familiesand the communitiesthey care for.”- Director, Global FieldMedical Center ofExcellenceExecutive Sponsor
Table of ContentsSecond Year OverviewGlobal Medical Excellence(Six months)Fellows will have the opportunity to: Engage with our StrategicRealization Office (SRO). Work on critical projectmanagement initiativesincluding but not limited tobusiness management, medicalaffairs planning processes,KPI/Metrics, congress support,insights, BD activities, launchreadiness, as well as the clinicaltraining program.Longitudinal FellowshipExperience - BD & DigitalInnovation (on-going)Fellows will have the opportunity to: Collaborate on projects thatalign to acquisitions, life cyclemanagement, and businessdevelopment workstreams. Assist in identifying of ourmedical unmet needs includingdigital innovations, training,disease support, literaturesearches, and medical strategy. Ensure our focused efforts arealigned to our central corevalues of being real, risingtogether, and maintaining ourpassion for our purpose.15“Founding fellows will gain a unique industry perspective with anew and rapidly developing organization. We’re at a critical stagein our development, focusing on unmet and under-met needs inWomen’s Health. Our fellows will have a deep and broadexperience in pharmaceuticals and devices that will provide astrong foundation to pursue future career interests.”- Kevin StarkExecutive Director, Global Labeling & Advertising PromotionExecutive Sponsor
Table of ContentsRutgers Institute for Pharmaceutical Industry FellowshipsErnest Mario School of Pharmacy – Rutgers, The State University of New JerseyProgram HistoryIn 1984, at Rutgers, The State University of New Jersey, the Ernest Mario School ofPharmacy and two pharmaceutical companies began a collaborative pilot program toevaluate the potential contributions of clinically-trained pharmacists within apharmaceutical industry practice setting. Following the successful pilot, the RutgersPharmaceutical Industry Fellowship (RPIF) Program grew significantly and expandedto include 21 companies within the pharmaceutical and biopharmaceutical industry andapproximately 300 Fellows.In 2002, Dr. Ernest Mario generously provided an endowment to establish theInstitute for Pharmaceutical Industry Fellowships to enhance and promote the roleof pharmacists in industry through the RPIF Program. The Institute staff members: provide leadership and administrative support; promote quality, communication, and scholarly activity; and arrange specialized fellowship training opportunities within the pharmaceuticaland biopharmaceutical industry.In 2018, our Program expanded to offer interdisciplinary Fellows’ training by addingselect physician fellowship opportunities to our well-established program.More than 1,300 Post-Doctoral Fellows have completed the RPIF Program, most ofwhom are experiencing influential and rewarding careers in the pharmaceutical andbiopharmaceutical industry throughout the US and abroad. The RPIF Program hasPreceptors and Mentors from industry who share their knowledge and experienceswith the Fellows through an intense but closely-guided training program. Assignmentsand projects are challenging, meaningful, and designed to enhance understanding ofthe pharmaceutical and biopharmaceutical industry and the Fellow’s functional area(s).Our goal is to provide the environment for Fellows to build the foundations for theircareers as future leaders in the industry.16The RPIF Program has thrived under the leadership of the founder, Dr. Joseph A.Barone, Dean and Professor II of the Ernest Mario School of Pharmacy, Dr.Carolyn Seyss, the Director for the Institute for Pharmaceutical IndustryFellowships, and Dr. Michael Toscani as Director Emeritus.Joseph A. Barone, Pharm.D., F.C.C.P.Dean and Professor IIErnest Mario School of PharmacyCarolyn Seyss, Pharm.D.Fellowship Director and RPIF AlumnaInstitute for Pharmaceutical Industry FellowshipsErnest Mario School of PharmacyMichael Toscani, Pharm.D.Research Professor, Fellowship Director EmeritusInstitute for Pharmaceutical Industry FellowshipsErnest Mario School of Pharmacy
Table of ContentsRutgers Institute for Pharmaceutical Industry FellowshipsProfessional Development SeriesRutgers, The State University of New JerseyAll Fellows gather once monthly as a group to participate in the ProfessionalDevelopment Day (PDD) series, an important component of their training thatcomplements the hands-on experience provided at the partner companies. ThePDDs are steered by a committee of Fellows and are designed to enhance theFellows’ leadership skills such as emotional intelligence, communication, criticaldecision making, and presentation skills. Fellows develop skill sets under theguidance of external trainers. PDDs also provide general knowledge about variousaspects of drug development/commercialization and issues facing thepharmaceutical and biopharmaceutical industry, and promote connectivity and asense of community among Fellows and alumni from different companies anddisciplines.Rutgers, The State University of New Jersey, with over 71,000 students in itsthree campuses, is one of the major state university systems in the UnitedStates. The New Jersey College of Pharmacy was founded in 1892 and wasincorporated into the University in 1927. The Ernest Mario School of Pharmacyis part of Rutgers Biomedical and Health Sciences, the only state school ofpharmacy in New Jersey, with approximately 1,350 students in its Doctor ofPharmacy degree program. The Rutgers Ernest Mario School of Pharmacy islocated on the University’s main science and technology campus in Piscataway,New Jersey. Because of its relationship with and, for most, close proximity tothe nation's leading pharmaceutical and biopharmaceutical companies, theErnest Mario School of Pharmacy and the RPIF Program are uniquely capableof providing fellows with advanced training in the pharmaceutical andbiopharmaceutical industry.The Fellows can learn from each other through individual and group presentationsand debates on topics and issues related to the pharmaceutical andbiopharmaceutical industry. The dynamic forum of PDD provides an opportunity foropen discussion and debate among fellows, Rutgers faculty, and companyPreceptors. In addition, outside experts provide training and professionaldevelopment in a variety of areas (e.g., tools for corporate success; professionalwriting, presentations, meeting facilitation, negotiating, influencing, networking, andconflict resolution skills; giving and receiving feedback; and business and diningetiquette). Other PDD guest speakers include senior industry executives, patientadvocacy groups, and successful RPIF Program alumni who share their insightsand experiences. Importantly, PDDs provide an excellent opportunity for Fellows tointeract with each other and develop lasting personal friendships and a strongprofessional network of Fellows, faculty, alumni, and other industry executives.17
Table of ContentsRutgers Institute for Pharmaceutical Industry FellowshipsKey Program FeaturesThe Rutgers Pharmaceutical Industry Fellowship Program FOSTERs the growth and development of future pharmaceutical andbiopharmaceutical industry professionals through the following key program features:FFamily of Leading Companies –OOutstanding Alumni Track Record – Over 1,300 alumni hold prominentSStrong Network – Fellows develop valuable, lasting connections with eachTERPartners include several of the topglobal pharmaceutical and biopharmaceutical companies.positions at many leading companies.other, alumni, Preceptors, and faculty.Trusted and Proven Since 1984 – the Rutgers Fellowship Program isnationally recognized, trusted, and proven as the key pathway to industryfor pharmacists as future leaders.Enhanced Career Development – Breadth of experiences informs careerpath choices and increasingly challenging assignments build depth ofexperience, enhancing the potential for accelerated career paths.Rigorous Academic Component – Rutgers affiliation provides academicand professional development opportunities.18
Table of ContentsRutgers Institute for Pharmaceutical Industry FellowshipsApplication Process and Eligibility RequirementsPharmacy Fellows for the Rutgers Pharmaceutical Industry Fellowship Program are selected on a nationally competitive basis. Candidates musthave completed a Doctor of Pharmacy degree from an ACPE-accredited institution before July 1 of the fellowship term.How to Apply:Interviewing is conducted on a rolling basis. Interested candidates may submit their application and supporting materials(letter of intent, curriculum vitae, and three letters of recommendation) during October 2021 by visiting our website at:pharmafellows.rutgers.eduAll application materials must be submitted electronically to the RPIF Website.Required ItemsDeadline*Letter of Intent (LOI)November 1stCurriculum Vitae (CV)November 1st3 Letters of Recommendation (LORs)December 5th*Candidates are considered on a rolling basis. Submission of materials prior to deadline is strongly encouraged.Your Letter of Intent & Letters of Recommendation should be addressed to:Joseph A. Barone, Pharm.D., F.C.C.P.Dean and Professor IIErnest Mario School of PharmacyRutgers, The State University of New Jersey160 Frelinghuysen RoadPiscataway, NJ 08854-802019
that women are the foundation to a healthier world. Our goal is to create a better and healthier every day, for every woman We are motivated by a woman's evolving health needs throughout her lifetime. That's why our intention is to take on some of the issues that matter most to her. We aim to empower women to make the
